These findings suggest that VEGF gene expression may be an activation marker in Behçet's disease patients with joint involvement and that VEGF-B may suggest new approaches in the treatment of arthritis patients with Behçet's disease. The gene discussed is VEGFB; the disease is Behcet disease.